:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	She, Jane, Chen, Xiaofei, Iyengar, Malini, Li, Judy
Format:	Preprint
Published:	2026
Subjects:	Applications
Online Access:	https://arxiv.org/abs/2602.21370
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Individual and Trial Level Association Metrics in the Validation of a Binary Surrogate Endpoint for a True Time-to-Event Endpoint
by: Ge, Renee Y., et al.
Published: (2026)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
by: Stijven, Florian, et al.
Published: (2025)

Distribution-Free Selection of Low-Risk Oncology Patients for Survival Beyond a Time Horizon
by: Sesia, Matteo, et al.
Published: (2025)

On Assessing Overall Survival (OS) in Oncology Studies
by: Hsu, Jason C.
Published: (2025)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Dynamic Classification of Latent Disease Progression with Auxiliary Surrogate Labels
by: Cai, Zexi, et al.
Published: (2024)

Considerations for Single-Arm Trials to Support Accelerated Approval of Oncology Drugs
by: Lu, Feinan, et al.
Published: (2024)

The Backfill i3+3 Design for Dose-Finding Trials in Oncology
by: Liu, Jiaxin, et al.
Published: (2023)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Nonparametric Bayesian Multi-Treatment Mixture Cure Survival Model with Application in Pediatric Oncology
by: Chang, Peter, et al.
Published: (2025)

Learning from Literature: Integrating LLMs and Bayesian Hierarchical Modeling for Oncology Trial Design
by: Gong, Guannan, et al.
Published: (2026)

Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
by: Yuan, Shijie, et al.
Published: (2023)

Network Meta Analysis of Mean Survival
by: Apsemidis, Anastasios, et al.
Published: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

The Modified Combo i3+3 Design for Novel-Novel Combination Dose-Finding Trials in Oncology
by: Liu, Jiaxin, et al.
Published: (2024)

Personalized Oncology: Feasibility of Evaluating Treatment Effects for Individual Patients
by: Jang, Lydia, et al.
Published: (2025)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
by: Coent, Q. Le, et al.
Published: (2025)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

A Novel Framework for Modeling Quarantinable Disease Transmission
by: Liu, Wenchen, et al.
Published: (2025)

Analyses and Concerns in Precision Medicine: A Statistical Perspective
by: Chen, Xiaofei
Published: (2024)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)

ResSurv: Cancer Survival Analysis Prediction Model Based on Residual Networks
by: Zhai, Wankang
Published: (2024)

Forecasting Medium-Horizon Alzheimer's Disease Progression: Residual Gap-Aware Transformers for 24-Month CDR-SB Change from ADNI Clinical and Biomarker Histories
by: Tong, Ran, et al.
Published: (2026)

Bayesian Nonparametric Causal Inference for Quantile Residual Life: An Application to Alzheimer's Disease
by: Bae, Woojung, et al.
Published: (2026)

Evaluating the Surrogate Index as a Decision-Making Tool Using 200 A/B Tests at Netflix
by: Zhang, Vickie, et al.
Published: (2023)

Causal Judge Evaluation: Calibrated Surrogate Metrics for LLM Systems
by: Landesberg, Eddie, et al.
Published: (2025)

Joint Modeling of Biomarker Cascades Along An Unobserved Disease Progression with Differentiate Covariate Effects: An Application in Alzheimer's Disease
by: Tang, Zhuojun, et al.
Published: (2023)

Application of Markov Chains to Multiple Sclerosis Clinical Trial Data to Estimate Disease Trajectories
by: Sthanu, Uma, et al.
Published: (2024)

Statistical Design and Rationale of the Biomarkers for Evaluating Spine Treatments (BEST) Trial
by: Sperger, John, et al.
Published: (2025)

SigBERT: Combining Narrative Medical Reports and Rough Path Signature Theory for Survival Risk Estimation in Oncology
by: Minchella, Paul, et al.
Published: (2025)

Surrogate Models to Predict Wave Hydrodynamics on Evolving Landscapes
by: Gharehtoragh, Mohammad Ahmadi, et al.
Published: (2025)

Mind the Jumps: A Scalable Robust Local Gaussian Process for Multidimensional Response Surfaces with Discontinuities
by: Adjetey, Isaac, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

A Plot is Worth a Thousand Tests: Assessing Residual Diagnostics with the Lineup Protocol
by: Li, Weihao, et al.
Published: (2023)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)